The market dynamics section of the report examines the diverse factors which govern the process of manufacturing, distribution, and usage of nucleic acid therapies globally. This analysis provides an in-depth understanding of the present and the future directions in which the market is headed and the impact of various factors on the same. This chapter covers the major market dynamics, namely, the drivers, challenges, business strategies, corporate strategies, and opportunities, analyzing several factors that positively and negatively affect the global nucleic acid therapeutics CDMO market.

An organ transplant is a surgical procedure to replace a healthy organ from a damaged organ. Organ transplant diagnostics are clinical diagnostic tools that help to improve the efficiency of transplantation procedures. HLA typing is of utmost importance in applications such as organ and blood stem cell transplantation. Organs that have been successfully transplanted include the kidneys, heart, liver, lungs, pancreas, and bone marrow transplants. The current study aims to assess the global organ transplant diagnostics market by focusing on products (kits, assays, and consumables) and services catering to end-users, including hospitals and transplants centers, academics and research centers, among others. The current market for organ transplant diagnostics is majorly dominated by manufacturers and service providers such as Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Thermo Fisher Scientific Inc. (One Lambda), bioMérieux S.A., Illumina, Inc., CareDx, Inc. and Laboratory Corporation of America Holdings.

The global ophthalmic drug delivery devices market is fragmented in nature, owing to the presence of various key drug delivery device companies. The major companies operating in the market include Aero Pump GmbH, Aptar Group, Inc., Bausch Health Companies Inc., Nemera, Ocular Therapeutix, Inc., and Gaplast GmbH. The companies offer a diverse product portfolio, including eyedroppers, squeeze dispensers, pre-filled and pre-fillable syringes, contact lenses, and ocular inserts. Furthermore, owing to the increasing technology penetration, various novel drug-device companies such as Kedalion Therapeutics, Inc., Re-Vana Therapeutics, Mati Therapeutics, Inc., Biocorp, and Ocumedic, Inc. have also entered the market.

3D printing is also known as additive printing technology, which allows manufacturers to build models using a variety of printing materials. Materials used for 3D printing include various types of polymers, metals, ceramics, and others. These printers feature extremely fine resin prints, utilizing a liquid base that is solidified using a UV light to create the solid objects. Personal 3D printers differ from professional-grade printers, in that they are much less expensive and the software needed to run them is much more user-friendly.

This study analyzes the global market for plastic, glass, aluminum, rubber and paper-based primary pharmaceutical packaging materials that include bottles, blister and strip packs, ampoules and vials, prefilled syringes, cartridges, tubes, canisters, caps and closures, and sachets. •These products are greatly valued in the pharmaceutical industry for storing and dispensing oral drugs, drops and sprays, topical medicines and suppositories, and injectables.

结核病由结核分枝杆菌感染引起，是一类慢性、传染性和致命性的疾病。随着耐多药和广泛耐药结核分枝杆菌的不断出现与快速传播，结核病治疗变得更加艰难，寻找新药成为当务之急。本文介绍近年来抗结核新药的研发进展。

The global pharmaceutical quality management software market has been segmented on the basis of application into corrective action preventive action (CAPA) management, audit management, document management, change management, training management, risk management, complaints management, regulatory and compliance management, non-conformances handling, supplier quality management, inspection management, equipment management, and others. The following figure indicates the different application types in the global pharmaceutical quality management software market along with the corresponding sub-segments.

Respiratory disposables are accessories that can be used with respiratory devices for using them as preventive measures and as therapeutics. Various sets of single-use disposables are used in diseases such as asthma, COPD, and other respiratory diseases. For the purpose of analysis, the report segments the global respiratory disposables market based on product, patient group, end user, and region. The report focusses on various respiratory disposable products available in the market such as laryngoscopes, tubes, breathing bag, masks, resuscitator, and others. The patient group considered in the study include neonatal & pediatric, adult, and pediatric. The major end users of respiratory disposables include hospitals, clinics, and trauma centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Moreover, it analyzes the current market trends of respiratory disposable across different regions such as North America, Europe, Asia-Pacific, and LAMEA and suggests the future growth opportunities.

从交易成本理论视角来看，生物医药孵化器具有实现创新资源共享、降低市场交易成本等作用，在运营发展过程中也会产生比较高的信息成本、协调成本及监督成本。分入孵、在孵两个阶段，分析提出我国生物医药孵化器运营成本问题的成因，主要包括信息共享不足、运行机制不够健全以及监督体系有待完善等，结合对美国强生JLabs生物医药孵化器的案例分析，从交易成本视角为降低我国生物医药孵化器运营成本、提高孵化能力，提出加强信息共享建设、制定健全运行机制和构建完善监督体系等具体对策建议。

Single-cell multiomics technologies typically measure numerous types of molecules from the same individual cell, allowing more profound biological insight than can be inferred by analyzing each molecular layer from separate cells. Single cell multiomics is the application of modern genomics methods that primarily include oncology, cell biology, neurology, stem cell, and immunology. The report provides market dynamics and trends related to the global single-cell multiomics technologies market. In addition, it presents the market estimations and forecast of the market. The valuations comprise revenue generated from sale of techniques and services. Furthermore, the report excludes revenue generated from post-sale services of single-cell multiomics technologies.